Fortis Healthcare Limited, based at the corporate office in Gurugram, Haryana, has announced the appointment of Mr. Leo Puri as the Chairman (Independent & Non-Executive) of its Board of Directors, effective 27 December 2024. Mr. Puri will play a crucial role in guiding Fortis Healthcare's strategic direction and operations at a group level, steering the organisation towards innovation, growth, and industry leadership.
Mr. Puri is an accomplished leader and financial sector veteran with over four decades of experience. Throughout his illustrious career, Mr. Puri has held several high-impact leadership roles in prominent global and Indian organisations, such as the Executive Chairman for South & Southeast Asia at JP Morgan Chase, Senior Partner at McKinsey & Company, Managing Director at UTI Asset Management Company, Managing Director and General Partner at Warburg Pincus and held several Board positions previously.
Currently, Mr. Puri serves on the boards of industry-leading organisations, including Tata Sons, Hindustan Unilever, and Dr. Reddy's Laboratories, further demonstrating his extensive expertise and strategic insight across diverse sectors.
Mr. Leo Puri, Chairman (Independent & Non-Executive), Fortis Healthcare Ltd, said, "I am proud to be working with the talented Fortis Healthcare team and supporting their mission of expanding quality healthcare access and affordability. The sector presents exciting opportunities for growth and employment creation, in support of India's National Health Policy. I look forward to building on the team's success, working closely with the board, management, dedicated clinicians, and all stakeholders."
Shares of Fortis Healthcare Limited was last trading in BSE at Rs. 682.20 as compared to the previous close of Rs. 671.95. The total number of shares traded during the day was 20760 in over 1095 trades.
The stock hit an intraday high of Rs. 685.50 and intraday low of 659.05. The net turnover during the day was Rs. 13982676.00. |
